{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:25:44Z","timestamp":1791278744764,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T00:00:00Z","timestamp":1388016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0085098","type":"journal-article","created":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T21:47:13Z","timestamp":1388094433000},"page":"e85098","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["9G4+ Antibodies Isolated from HIV-Infected Patients Neutralize HIV-1 and Have Distinct Autoreactivity Profiles"],"prefix":"10.1371","volume":"8","author":[{"given":"Danielle C.","family":"Alc\u00e9na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Kobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander F.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonelle L.","family":"Mattiacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Dewhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Dykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Keefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,12,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1128\/JVI.00110-09","article-title":"Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm","volume":"83","author":"MD Simek","year":"2009","journal-title":"J Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1001251","DOI":"10.1371\/journal.ppat.1001251","article-title":"Characteristics of the earliest cross-neutralizing antibody response to HIV-1","volume":"7","author":"I Mikell","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.coi.2011.04.003","article-title":"Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies","volume":"23","author":"L Verkoczy","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature09385","article-title":"Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation","volume":"467","author":"H Mouquet","year":"2010","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1126\/science.1111781","article-title":"Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies","volume":"308","author":"BF Haynes","year":"2005","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/HAB-2005-143-402","article-title":"Antibody polyspecificity and neutralization of HIV-1: a hypothesis","volume":"14","author":"BF Haynes","year":"2005","journal-title":"Hum Antibodies"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1371\/journal.pone.0035356","article-title":"9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity","volume":"7","author":"JJ Kobie","year":"2012","journal-title":"PLOS ONE"},{"key":"ref8","first-page":"2114","article-title":"VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype","volume":"29","author":"NM Bhat","year":"2002","journal-title":"J Rheumatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jaut.1993.1066","article-title":"Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus","volume":"6","author":"FK Stevenson","year":"1993","journal-title":"J Autoimmun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1084\/jem.178.4.1419","article-title":"Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment","volume":"178","author":"KN Potter","year":"1993","journal-title":"J Exp Med"},{"key":"ref11","first-page":"299","article-title":"Use of a cross reacting anti-idiotype to identify normal counterparts of neoplastic cells","volume":"30","author":"FK Stevenson","year":"1988","journal-title":"Nouv Rev Fr Hematol"},{"key":"ref12","first-page":"2013","article-title":"9G4+ auto-antibodies are an important source of apoptotic cell reactivity associated with high disease activity in systemic lupus erythematosus","author":"SA Jenks","year":"2013","journal-title":"Arthritis and rheumatism"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/icb.2011.108","article-title":"Pathogenicity and proteomic signatures of autoantibodies to Ro and La","volume":"90","author":"R Lindop","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00467-011-2078-4","article-title":"Autoantibodies in systemic lupus erythematosus","volume":"27","author":"SD Marks","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.4049\/jimmunol.172.11.6692","article-title":"Nucleosomes are exposed at the cell surface in apoptosis","volume":"172","author":"M Radic","year":"2004","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.4049\/jimmunol.172.7.4298","article-title":"Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45\/B220 on the surface of human B lymphocytes","volume":"172","author":"AJ Cappione","year":"2004","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2249.1996.d01-733.x","article-title":"Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies","volume":"105","author":"NM Bhat","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1172\/JCI200112462","article-title":"Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance","volume":"108","author":"AE Pugh-Bernard","year":"2001","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1172\/JCI24179","article-title":"Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus","volume":"115","author":"A Cappione 3rd","year":"2005","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1186\/ar3542","article-title":"Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor","volume":"13","author":"JJ Kobie","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.vaccine.2011.01.038","article-title":"Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env","volume":"29","author":"J Mattiacio","year":"2011","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"10103","DOI":"10.1128\/JVI.79.16.10103-10107.2005","article-title":"Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines","volume":"79","author":"JR Mascola","year":"2005","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.4049\/jimmunol.1202263","article-title":"Molecular Basis of 9G4 B Cell Autoreactivity in Human Systemic Lupus Erythematosus","volume":"191","author":"C Richardson","year":"2013","journal-title":"J Immunol"},{"key":"ref24","first-page":"60","article-title":"Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes","volume":"147","author":"QZ Li","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1211s64","article-title":"Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays","author":"DC Montefiori","year":"2005","journal-title":"Curr Protoc Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1191\/0961203304lu1031oa","article-title":"B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells","volume":"13","author":"RJ Looney","year":"2004","journal-title":"Lupus"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1182\/blood.V83.10.2952.2952","article-title":"Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments","volume":"83","author":"P Riboldi","year":"1994","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar3927","article-title":"Autoantibody profiling to follow evolution of lupus syndromes","volume":"14","author":"NJ Olsen","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1038\/jid.2012.207","article-title":"IgG and IgM autoantibody differences in discoid and systemic lupus patients","volume":"132","author":"BF Chong","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e7215","DOI":"10.1371\/journal.pone.0007215","article-title":"Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external region","volume":"4","author":"L Verkoczy","year":"2009","journal-title":"PLOS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0085098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T22:39:23Z","timestamp":1597271963000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0085098"}},"subtitle":[],"editor":[{"given":"Aftab\u00a0A.","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,26]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0085098","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,26]]}}}